Degenerative periodontal-diseases and oral osteonecrosis: The role of gene-environment interactions

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 667, Issue 1-2, 2009, Pages 118-131

  Baldi, D ^a   Izzotti, A ^b   Bonica, P ^a   Pera, P ^a   Pulliero, A ^b  

^a Dentistry Sciences and Technologies   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Genetic susceptibility; Genotoxic risk factors; Oral osteonecrosis; Periodontal diseases

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; BISPHOSPHONIC ACID DERIVATIVE; CYCLOSPORIN; CYTOCHROME P450 1A1; CYTOKINE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; METALLOPROTEINASE; PROTHROMBIN;

BONE ATROPHY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHRONIC INFLAMMATION; CIGARETTE SMOKING; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; DNA DAMAGE; DNA REPAIR; DRUG EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME POLYMORPHISM; GENOTOXICITY; HEREDITY; HUMAN; IONIZING RADIATION; JAW OSTEONECROSIS; MUTAGENESIS; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTITIS; PRIORITY JOURNAL; PUBLIC HEALTH; RADIATION EXPOSURE; REVIEW;

CHRONIC DISEASE; DNA DAMAGE; DNA, MITOCHONDRIAL; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; JAW DISEASES; OSTEONECROSIS; PERIODONTAL DISEASES; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 67649297102     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.11.005     Document Type: Review

References (118)

1. Canakçi C.F., Tatar A., Canakçi V., Cicek Y., Oztas S., and Orbak R. New evidence of premature oxidative DNA damage: mitochondrial DNA deletion in gingival tissue of patients with periodontitis. J. Periodontol. 77 (2006) 1894-1900
2. Albandar J.M., and Rams T.E. Periodontol 2000 Global epidemiology of periodontal diseases 29 (2002), Munksgaard Blackwells, Copenhagen, Denmark
3. Hugoson A., Koch G., Göthberg C., Helkimo A.N., Lundin S.A., Norderyd O., Sjödin B., and Sondell K. Oral health of individuals aged 3-80 years in Jönköping, Sweden during 30 years (1973-2003). I. Review of findings on dental care habits and knowledge of oral health. Swed. Dent. J. 29 (2005) 125-138
4. Háber J., Kolesková E., Kostelková A., Klener P., Slavícek A., Palecek A., and Másová I. Treatment of oropharyngeal and esophageal mycoses in immunodeficient patients with fluconazole (Diflucan, Pfizer). Cas Lek Cesk 132 (1993) 745-749
5. Gelskey S.C. Cigarette smoking and periodontitis: methodology to assess the strength of evidence in support of a causal association. Commun. Dent. Oral Epidemiol. 27 (1999) 16-24
6. Hyman J.J., and Reid B.C. Epidemiologic risk factors for periodontal attachment loss among adults in the United States. J. Clin. Periodontol. 30 (2003) 230-237
7. Meisel P., Siegemund A., Grimm R., Herrmann F.H., John U., Schwahn C., and Kocher T. The interleukin-1 polymorphism, smoking, and the risk of periodontal disease in the population-based SHIP study. J. Dent. Res. 82 (2003) 189-193
8. Albandar J.M. Periodontal diseases in North America. Periodontol. 2000 29 (2002) 31-69
9. Bagan J.V., Murillo J., Jiemenez Y., Poveda R., Milian M.A., Sanchis J.M., Silvestre F.J., and Scully C. Avascular jaw osteonecrosis in association with cancer chemiotherapy: series of 10 cases. J. Oral Pathol. Med. 34 (2005) 120-123
10. Niehoff P., Springer I.N., Açil Y., Lange A., Marget M., Roldán J.C., Köppe K., Warnke P.H., Kimmig B., and Wiltfang J. HDR brachytherapy irradiation of the jaw-as a new experimental model of radiogenic bone damage. J. Craniomaxillofac. Surg. 36 (2008) 203-209
11. Izzotti A., Cartiglia C., Longobardi M., Balansky R.M., D'Agostini F., Lubet R.A., and De Flora S. Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke. FASEB J. 18 (2004) 1559-1561
12. Lalla E., Lamster I.B., Drury S., Fu C., and Schmidt A.M. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts. Periodontology 23 (2000) 50-62
13. Rodriguez T., Altieri A., Chatenoud L., Gallus S., Bosetti C., Negri E., Franceschi S., Levi F., Talamini R., and La Vecchia C. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol. 40 (2004) 207-213
14. Shiu M.N., and Chen T.H. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur. J. Cancer Prev. 13 (2004) 39-45
15. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567 (2004) 447-474
16. Wu P.A., Loh C.H., Hsieh L.L., Liu T.Y., Chen C.J., and Liou S.H. Clastogenic effect for cigarette smoking but not areca quid chewing as measured by micronuclei in exfoliated buccal mucosal cells. Mutat. Res. 562 (2004) 27-38
17. Suhas S., Ganapathy K.S., Gayatri Devi M., and Ramesh C. Application of the micronucleus test to exfoliated epithelial cells from the oral cavity of beedi smokers, a high-risk group for oral cancer. Mutat. Res. 561 (2004) 15-21
18. Duthie S.J., and Hawdon A. DNA instability strand breakage, uracil misincorporation, and defective repair is increased by folic acid depletion in human lymphocytes in vitro. FASEB J. 12 (1998) 1491-1497
19. Kim Y.I., Pogribny I.P., Basnakian A.G., Miller J.W., Selhub J., James S.J., and Mason J.B. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am. J. Clin. Nutr. 65 (1997) 46-52
20. Gabriel H.E., Crott J.W., Ghandour H., Dallal G.E., Choi S.W., Keyes M.K., Jang H., Liu Z., Nadeau M., Johnston A., Mager D., and Mason J.B. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adult. Am. J. Clin. Nutr. 83 (2006) 835-841
21. Izzotti A., Balansky R.M., Blagoeva P.M., Mircheva Z.I., Tulimiero L., Cartiglia C., and De Flora S. DNA alterations in rat organs after chronic exposure to cigarette smoke and/or ethanol ingestion. FASEB J. 12 (1998) 753-758
22. Koshi R., Sugano N., Orii H., Fukuda T., and Ito K. Microarray analysis of nicotine-induced changes in gene expression in a macrophage-like human cell line. J. Periodontal Res. 42 (2007) 518-526
23. Izzotti A., Balansky R.M., Cartiglia C., Camoirano A., Longobardi M., and De Flora S. Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke. FASEB J. 17 (2003) 1127-1129
24. Lombard D.B., Chua K.F., Mostoslavsky R., Franco S., Gostissa M., and Alt F.W. DNA repair, genome stability, and aging. Cell 120 (2005) 497-512
25. Katsuragi H., Hasegawa A., and Saito K. Distribution of metallothionein in cigarette smokers and non-smokers in advanced periodontitis patients. J. Periodontol. 68 (1997) 1005-1009
26. Development of a classification system for periodontal diseases and conditions. Consensus Conference 1999. Ann. Periodontol. 4 (1999) 1-6
27. Miyzaki H., Pilot T., Leclercq M.H., and Barmes D.E. Profiles of periodontal conditions in adolescents measured by CPITN. Int. Dent. J. 41 (1991) 67-73
28. Miyzaki H., Pilot T., Leclercq M.H., and Barmes D.E. Profiles of periodontal conditions in adolescents measured by CPITN. Int. Dent. J. 41 (1991) 74-80
29. World Workshop in Periodontics Consensus Report. Ann. Periodontol. 1 (1996)
30. Eick S., Reissmann A., Rödel J., Schmidt K.H., and Pfister W. Porphyromonas gingivalis survives within KB cells and modulates inflammatory response. Oral Microbiol. Immunol. 21 (2006) 231-237
31. Zilm P.S., and Rogers A.H. Co-adhesion and biofilm formation by Fusobacterium nucleatum in response to growth pH. Anaerobe 13 (2007) 146-152
32. Shemesh M., and Tam A. Expression of biofilm-associated genes of Streptococcus mutans in response to glucose and sucrose. J. Med. Microbiol. 56 (2007) 1528-1535
33. Barr C., Lopez M.R., and Rua-Dobles A. Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. J. Clin. Periodontol. 19 (1992) 794-801
34. Tezal M., Wactawski-Wende J., Grossi S.G., Ho A.W., Dunford R., and Genco R.J. The relationship between bone mineral density and periodontitis in a postmenopausal women. J. Periodontol. 71 (2000) 1492-1498
35. Laine M.L., Morré S.A., Murillo L.S., van Winkelhoff A.J., and Peña A.S. CD14 and TLR4 gene polymorphisms in adult periodontitis. J. Dent. Res. 84 (2005) 1042-1046
36. Kusumoto Y., Hirano H., Saitoh K., Yamada S., Takedachi M., Nozaki T., Ozawa Y., Nakahira Y., Saho T., Ogo H., Shimabukuro Y., Okada H., and Murakami S. Human gingival epithelial cells produce chemotactic factors interleukin-8 and monocyte chemoattractant protein-1 after stimulation with Porphyromonas gingivalis via toll-like receptor 2. J. Periodontol. 75 (2004) 370-379
37. Nisapakultorn K., Ross K.F., and Herzberg M.C. Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect. Immun. 69 (2001) 4242-4247
38. Huang G.T., Zhang H.B., Dang H.N., and Haake S.K. Differential regulation of cytokine genes in gingival epithelial cells challenged by Fusobacterium nucleatum and Porphyromonas gingivalis. Microb. Pathog. 37 (2004) 303-312
39. Papaioannou W., Cassiman J.J., Van den Oord J., De Vos R., van Steenberghe D., and Quirynen M. Multi-layered periodontal pocket epithelium reconstituted in vitro: histology and cytokeratin profiles. J. Periodontol. 70 (1999) 668-678
40. Page J.A. Dental health attitudes in Somerset: report of a dental health activity. Dent. Health 25 (1987) 3-4
41. De Flora S., Scarfì S., Izzotti A., D'Agostini F., Chang C.C., Bagnasco M., De Flora A., and Trosko J.E. Induction by 7,12-dimethylbenz(a)anthracene of molecular and biochemical alterations in transformed human mammary epithelial stem cells, and protection by N-acetylcysteine. Int. J. Oncol. 29 (2006) 521-529
42. Lee H.W., Blasco M.A., Horner W.C., Greider W., and DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 392 (1998) 569-574
43. Gronthos S., Mankani M., Brahim J., Robey P.G., and Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 25 (2000) 13625-13630
44. Thesleff I. Epithelial-mesenchymal signalling regulating tooth morphogenesis. J. Cell. Sci. 116 (2003) 1647-1648
45. Fong C.D., and Hammarstrom L. Expression of amelin and amelogenin in epithelial root sheath remnants of fully formed rat molars. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90 (2000) 218-223
46. Morsczeck C. Gene expression of runx2, Osterix, c-fos, DLX-3, DLX-5, and MSX-2 in dental follicle cells during osteogenic differentiation in vitro. Calcif. Tissue Int. 78 (2006) 98-102
47. Seo B.M., Miura M., Gronthos S., Bartold P.M., Batouli S., Brahim J., Young M., Robey P.G., Wang C.Y., and Shi S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364 (2004) 149-155
48. Kawanabe N., Murakami K., and Takano-Yamamoto T. The presence of ABCG2-dependent side population cells in human periodontal ligaments. Biochem. Biophys. Res. Commun. 16 (2006) 1278-1283
49. Jenkins W.M., and Kinane D.F. The 'high risk' group in periodontitis. Br. Dent. J. 167 (1989) 168-171
50. Page R.C., and Beck J.D. Risk assessment for periodontal diseases. Int. Dent. J. 47 (1997) 61-87
51. Bolt H.M., and Their R. Relevance of the deletion polymorphisms of the glutathione S transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab. 7 (2006) 613-628
52. Concolino P., Cecchetti F., D'Autilia C., Santonocito C., Di Stasio E., Zuppi C., Arcuri C., Deli G., Giardina B., Capoluongo E., and Ameglio F. Association of periodontitis with GSTM1/GSTT1-null variants-a pilot study. Clin. Biochem. 40 (2007) 939-945
53. Meisel P., Timm R., Sawaf H., Fanghänel J., Siegmund W., and Kocher T. Polymorphism of the N-acetyltransferase (NAT2), smoking and the potential risk of periodontal disease. Arch. Toxicol. 74 (2000) 343-348
54. Kocher T., Langenbeck N., Rosin M., and Bernhardt O. Methodology of three-dimensional determination of root surface roughness. J. Periodontal Res. 37 (2002) 125-131
55. Kalow W., and Tang B.K. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin. Pharmacol. Ther. 49 (1991) 44-48
56. Kim J.S., Park J.Y., Chung W.Y., Choi M.A., Cho K.S., and Park K.K. Polymorphisms in genes coding for enzymes metabolizing smoking-derived substances and the risk of periodontitis. J. Clin. Periodontol. 31 (2004) 959-964
57. Gunsolley J.C., Pandey J.P., Quinn S.M., Tew J., and Schenkein H.A. The effect of race, smoking and immunoglobulin allotypes on IgG subclass concentrations. J. Periodontal Res. 32 (1997) 381-387
58. Hasui Y., Hamanaka Y., Okayama N., Suehiro Y., Shinozaki F., Ueyama Y., and Hinoda Y. Association of the OGG1 Ser326Cys polymorphism with tooth loss. J. Clin. Lab. Anal. 20 (2006) 47-51
59. Gürkan A., Emingil G., Cinarcik S., and Berdeli A. Post-treatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fluid transforming growth factor-beta1 in severe, generalized chronic periodontitis. Int. J. Dent. Hyg. 6 (2008) 84-92
60. Ishihara Y., Zhang J.B., Fakher M., Best A.M., Schenkein H.A., Barbour S.E., and Tew J.G. Non-redundant roles for interleukin-1 alpha and interleukin-1 beta in regulating human IgG2. J. Periodontol. 72 (2001) 1332-1339
61. Kornman K.S., Crane A., Wang H.Y., di Giovine F.S., Newman M.G., Pirk F.W., Wilson Jr. T.G., Higginbottom F.L., and Duff G.W. The interleukin-1 genotype as a severity factor in adult periodontal disease. J. Clin. Periodontol. 24 (1997) 72-77
62. Armitage G.C. Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 4 (1999) 1-6
63. Cattabriga M., Rotundo R., Muzzi L., Nieri M., Verrocchi G., Cairo F., and Pini Prato G. Retrospective evaluation of the influence of the interleukin-1 genotype on radiographic bone levels in treated periodontal patients over 10 years. J. Periodontol. 72 (2001) 767-773
64. Diehl S.R., Wang Y., Brooks C.N., Burmeister J.A., Califano J.V., Wang S., and Schenkein H.A. Linkage disequilibrium of interleukin-1 genetic polymorphisms with early-onset periodontitis. J. Periodontol. 70 (1999) 418-430
65. Parkhill J.M., Hennig B.J., Chapple I.L., Heasman P.A., and Taylor J.J. Association of interleukin-1 gene polymorphisms with early-onset periodontitis. J. Clin. Periodontol. 27 (2000) 682-689
66. Hodge P.J., Teague P.W., Wright A.F., and Kinane D.F. Clinical and genetic analysis of a large North European Caucasian family affected by early-onset periodontitis. J. Dent. Res. 79 (2000) 857-863
67. Galbraith G.M., Steed R.B., Sanders J.J., and Pandey J.P. Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J. Periodontol. 69 (1998) 428-433
68. Craandijk J., van Krugten M.V., Verweij C.L., van der Velden U., and Loos B.G. Tumor necrosis factor-alpha gene polymorphisms in relation to periodontitis. J. Clin. Periodontol. 29 (2002) 28-34
69. Van Schie R.C., and Wilson M.E. Saliva: a convenient source of DNA for analysis of bi-allelic polymorphisms of Fc gamma receptor IIA (CD32) and Fc gamma receptor IIIB (CD16). J. Immunol. Methods 208 (1997) 91-101
70. Sanders B.J., Weddell J.A., and Dodge N.N. Managing patients who have seizure disorders: dental and medical issues. J. Am. Dent. Assoc. 126 (1995) 1641-1647
71. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J. Oral Maxillofac. Surf. 65 (2007) 369-376
72. L.A.G. Ries, D. Melbert, M. Krapcho, D.G. Stinchcomb, N. Howlader, M.J. Horner, A. Mariotto, B.A. Miller, E.J. Feuer, S.F. Altekruse, D.R. Lewis, L. Clegg, M.P. Eisner, M. Reichman, B.K. Edwards, SEER Cancer Statistics Review, 1975-2005, National Cancer Institute, Bethesda, http://seer.cancer.gov/crs/1975-2000, 2008.
73. Wilder L., Jaeggi K.A., Glatt M., Müller K., Bachmann R., Bisping M., Born A.R., Cortesi R., Guiglia G., Jeker H., Klein R., Ramseier U., Schmid J., Schreiber G., Seltenmeyer Y., and Green J.R. Higly potent geminal bisphosphonates. From pamidronate disodium to zolendronic acid. J. Med. Chem. 45 (2002) 3721-3738
74. Marx R.E. Pamidronate and zolendronate induced avascular necrosis of the jaws: a growing epidemic. J. Oral Maxillofac. Surg. 62 (2004) 527-534
75. Berenson J.R., Rosen L.S., Howell A., Porter L., Coleman R.E., Morley W., Dreicer R., Kuross S.A., Lipton A., and Seaman J.J. Zolendronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer 91 (2001) 1191-1200
76. Mönkkönen H., Ottewell P.D., Kuokkanen J., Mönkkönen J., Auriola S., and Holen I. Zoledronic acid-induced IPP/ApppI production in vivo. Life Sci. 81 (2007) 1066-1070
77. Shane E., Goldring S., Christakos S., Drezner M., Eisman J., Silverman S., and Pendrys D. Osteonecrosis of the jaw: more research needed. J. Bone Miner. Res. 21 (2006) 1503-1505
78. Tosi G.M., Schiff W., Barile G., Yoshida N., and Chang S. Management of severe hypotony with intravitreal injection of viscoelastic. Am. J. Ophthalmol. 140 (2005) 952-954
79. Dimitrakopoulos I., Magopoulos C., and Karakasis D. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Int. J. Oral Maxillofac. Surg. 35 (2006) 588-593
80. Durie B.G.M., Katz M., and Crowley J. Osteonecrosis of the jaws and bisphosphonates. N. Engl. J. Med. 99 (2005) 353
81. AIFA, www.agenziafarmaco.it.
82. Woo S.B., Hellstein J.W., and Kalmar J.R. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann. Intern. Med. 144 (2006) 753-761
83. Lane N.E. Epidemiology ethiology and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 194 (2006) S3-S11
84. National Osteoporosis Foundation, Fast facts, http://www.nof.org/osteoporosis/diseasefact.htm.
85. Badros A., Weikel D., Salama A., Goloubeva O., Schneider A., Rapoport A., Fenton R., Gahres N., Sausville E., Ord R., and Meiller T. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J. Clin. Oncol. 24 (2006) 945-952
86. Roelofs A.J., Thompson K., Gordon S., and Rogers M.J. Molecular mechanisms of action of bisphosphonates: current status. Clin. Cancer Res. 12 (2006) 62225-62305
87. Wood J., Bonjean K., Ruerz S., Bellahcène A., Devy L., Foidart J.M., Castronovo V., and Green J.R. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J. Pharmacol. Exp. Ther. 302 (2002) 1055-1061
88. Lin J.H., and Bisphosphonates:. A review of their pharmacokinetic properties. Bone 18 (1996) 75-85
89. Rosen L.S., Gordon D., Kaminski M., Howell A., Belch A., Mackey J., Apffelstaedt J., Hussein M., Coleman R.E., Reitsma D.J., Seaman J.J., Chen B.L., and Ambros Y. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J. 7 (2001) 377-387
90. Wessel J.H., Dodson T.B., and Zavras A.I. Zoledronate smoking and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J. Oral Maxillofac. Surg. 66 (2008) 625-631
91. Ruggiero S.L., Mehrotra B., Rosemberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J. Oral Maxillofac. Surg. 62 (2004) 527-534
92. Elder G.J. From marrow oedema to osteonecrosis: common paths in the development of post-transplant bone pain. Nephrology (2006) 11560-11567
93. Fukuda A., Hikita A., Wakeyama H., Akiyama T., Oda H., Nakamura K., and Tanaka S. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J. Bone Miner. Res. 20 (2005) 2245-2253
94. Wang Y., Lebowitz D., Sun C., Thang H., Grynpas M.D., and Glogauer M. Identifying the Relative Contributions of Rac1 and Rac2 to Osteoclastogenesis. J. Bone Miner. Res. 23 (2008) 260-270
95. Pool B.L., Berger M., Schlehofer J.R., and Wingen F. In vivo and in vitro investigations on biological effects of aromaticbis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed forchemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. typhimurium. Invest. New Drugs 6 (1988) 67-78
96. Plotkin L.I., Lezcano V., Thostenson J., Weinstein R.S., Manolagas S.C., and Bellido T. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J. Bone Miner. Res. 2 (2008)
97. Plotkin L.I., and Bellido T. Bisphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: a gap junction-independent action of connexin 43. Cell Commun. Adhes. 8 (2001) 377-382
98. Assouline-Dayan Y., Chang C., Greenspan A., Shoenfeld Y., and Gershwin M.E. Pathogenesis and natural history of osteonecrosis. Semin. Arthritis Rheum. 32 (2002) 94-124
99. Goldwaser B.R., Chuang S.K., Kaban L.B., and August M. Risk factor assessment for the development of osteoradionecrosis. J. Oral Maxillofac. Surg. 65 (2007) 2311-2316
100. Borel J.F. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology 31 (1976) 631-641
101. Marx R.E., Cillo Jr. J.E., and Ulloa J.J. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J. Oral Maxillofac. Surg. 65 (2007) 2397-2410
102. Bagan J.V., Jiménez Y., Gómez D., Sirera R., Poveda R., and Scully C. Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates. Oral. Oncol. (2008) Apr 5. [Epub ahead of print]
103. Tiu J., Li H., Rassekh C., van der Sloot P., Kovach R., and Zhang P. Molecular basis of posttransplant squamous cell carcinoma: the potential role of cyclosporine A in carcinogenesis. Laryngoscope 116 (2006) 762-769
104. Meller A.T., Rumjanek V.M., Sansone C., and Allodi S. Oral mucosa alterations induced by cyclosporin in mice: morphological features. J. Periodontal Res. 37 (2002) 412-415
105. Spetch L. Oral complications in the head and neck irradiated patient. Introduction and scope of the problem. Supp. Care Dent. 10 (2002) 36-39
106. Vanderpuye V., and Goldson A. Osteoradionecrosis of the mandible. J. Natl. Med. Assoc. 92 (2000) 579
107. Sulaiman F., Huryn J.M., and Zlotolow I.M. Dental extractions in the irradiated head and neck patient: a retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria, and end results. J. Oral Maxillofac. Surg. 61 (2003) 1123-1131
108. Morrish.F R.B. Jr., ChanF E., Silverman S., Meyer J., Fu K.K., and Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer 47 (1981) 1980-1983
109. Thorn J.J., Hansen H.S., Specht L., and Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J. Oral Maxillofac. Surg. 58 (2000) 1088-1093
110. Marx R.E., Johnson R.P., and Kline S.N. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J. Am. Dent. Assoc. 111 (1985) 49-54
111. Sarasquete M., García-Sanz R., Marín L., Alcoceba M., Chillón M., Balanzategui A., Santamaria C., Rosiñol L., de la Rubia J., Hernandez M., Garcia-Navarro I., Lahuerta J.J., González M., and San Miguel J.F. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. Blood 112 (2008) 709-712
112. Ingelman-Sundberg M., Sim S.C., Gomez A., and Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther. 116 (2007) 496-526
113. Fleming I. Epoxyeicosatrienoic acids, cell signaling and angiogenesis. Prostaglandins Other Lipid Mediat. 82 (2007) 60-67
114. Björkman A., Burtscher I.M., Svensson P.J., Hillarp A., Besjakov J., and Benoni G. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the Knee. Arch. Orthop. Trauma Surg. 125 (2005) 51-55
115. Zalavras C.G., Patzakis M.J., Thordarson D.B., Shah S., Sherman R., and Holtom P. Infected fractures of the distal tibial metaphysis and plafond: achievement of limb salvage with free muscle flaps, bone grafting, and ankle fusion. Clin. Orthop. Relat. Res. 427 (2004) 57-62
116. Chang J.D., Hur M., Lee S.S., Yoo J.H., and Lee K.M. Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population. Clin. Orthop. Relat. Res. 466 (2008) 1041-1046
117. Kohler H.P., and Grant P.J. Plasminogen-activator inhibitor type 1 and coronary artery disease. N. Engl. J. Med. 342 (2000) 1792-1801
118. Asano T., Takahashi K.A., Fujioka M., Inoue S., Okamoto M., and Sugioka N. ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation. Pharmacogenetics 13 (2003) 675-682